Clinical trial
TNFerade™ Biologic Plus Radiation for Metastatic Melanoma
NCT00261404 · GenVec, Industry · Completed
Key facts
| NCT number | NCT00261404 |
|---|---|
| Title | TNFerade™ Biologic Plus Radiation for Metastatic Melanoma |
| Official title | A Phase II, Open Label, Single Arm, "Proof of Concept" Study of TNFerade™ Plus Radiation in Patients With Metastatic Melanoma |
| Lead sponsor | GenVec, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma |
| Intervention type | Drug |
| Interventions | TNFerade™ |
| First posted | Dec 5, 2005 |
| Last update posted | May 12, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: